Expertise in the product development lifecycle
Active Awarded Last action
- Contract number
- 75N93024F00006
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $536,931
Award facts
- Contract value 12% obligated
-
- $536,931.00 Current, with exercised options
- $4,328,663.00 Potential, with all options
- Completion date 36% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract, valued at $4,328,663.00, is for expertise in the product development lifecycle, including services such as cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, and project management for infectious disease countermeasures. The contract is a Delivery Order under the Resources to Advance Pediatrics and HIV Prevention Science Indefinite Delivery Vehicle (IDV), a $98.9 million IDV with NIAID that covers a range of preclinical development support services. The contract does not have a set-aside designation, as ABL is a large, for-profit foreign-owned manufacturer of goods. ABL has supported various NIH programs, including HIV microbicides, pediatric drug formulation development, and cancer prevention initiatives, through its federal contract and grant awards.
Quick answers
Who was awarded contract 75N93024F00006?
75N93024F00006 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2024.
How much is contract 75N93024F00006 worth?
The government has obligated $536,931 on 75N93024F00006. Its potential value, with all options, is $4,328,663.
Is contract 75N93024F00006 an order under another contract?
Yes. 75N93024F00006 is a delivery order under 75N93023D00001, an indefinite delivery contract, on Resources to Advance Pediatrics and HIV Prevention Science.
Was contract 75N93024F00006 competed?
The extent of competition for 75N93024F00006 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award